ScreenerHero
RVXResverlogix Corp.
TSX · CA · Healthcare · Biotechnology · resverlogix.com
0.1100CAD0.00%Mkt Cap: 21.93M $P/E: —

Resverlogix Corp., a late-stage clinical biotechnology company, develops therapeutics for patients with chronic illnesses. Its lead drug is apabetalone (RVX-208), a small molecule selective bromodomain and extra-terminal…

Industry Peers

Biotechnology
Screen all
VX1
Vertex Pharmaceuticals Incorporated
$130.23BUSDP/E 32.1
VRTX
Vertex Pharmaceuticals Incorporated
$139.84BUSDP/E 32.2
REGN
Regeneron Pharmaceuticals, Inc.
$85.11BUSDP/E 20.4
MRNA
Moderna, Inc.
$69.62BUSD
ARGX
ARGENX SE
$60.19BUSDP/E 39.1
UCB
UCB SA
$45.16BUSDP/E 19.2
RVMD
Revolution Medicines, Inc.
$46.01BUSD
ONC
BeOne Medicines AG
$41.76BUSDP/E 66.2
RPRX
Royalty Pharma Plc Class A
$35.67BUSDP/E 33.2
ALNY
Alnylam Pharmaceuticals, Inc.
$32.46BUSDP/E 42.3
INSM
Insmed Incorporated
$28.53BUSD
22UA
BioNTech SE
$26.14BUSD
INCY
Incyte Corporation
$25.79BUSDP/E 16.2
GMAB
Genmab A/S
$20.83BUSDP/E 26.3
GMAB
Genmab A/S
$19.17BUSDP/E 26.2
ASND
Ascendis Pharma A/S
$17.03BUSDP/E 20.0
BBIO
BridgeBio Pharma, Inc.
$16.41BUSD
EXEL
Exelixis, Inc.
$13.48BUSDP/E 17.1
BMRN
BioMarin Pharmaceutical Inc.
$13.42BUSDP/E 187.4
CORT
Corcept Therapeutics Incorporated
$12.87BUSDP/E 264.5

Key Statistics

Company
Market Cap21.93M $
Enterprise Value78.71M $
Revenue (TTM)—
Gross Profit—
Net Income (TTM)-5.66M $
Revenue/Share—
Last Price0.1100 CAD
Fiscal Year EndDec 2025
MR QuarterJun 2026
Employees—
CountryCA
SectorHealthcare
IndustryBiotechnology
ISIN—
Valuation
P/E (Trailing)—
P/E (Forward)-0.45
PEG—
EV/EBITDA-22.65
EV/Revenue—
P/S—
P/B-0.23
EPS (TTM)-0.03
EPS (Forward)—
52W Range
0.085038% of range0.1500
52W High0.1500 CAD
52W Low0.0850 CAD
Profitability
Gross Margin0.00%
Oper. Margin0.00%
EBITDA Margin0.00%
Profit Margin0.00%
ROE8.73%
ROA-97.72%
Growth
Revenue Growth—
Earnings Growth—
Cash Flow & Leverage
Operating CF-2.67M $
CapEx (TTM)506.87K $
FCF Margin—
FCF Yield31.57%
Net Debt56.56M $
Net Debt/EBITDA-16.28
Balance Sheet
Debt/Equity-0.23
Current Ratio0.04
Quick Ratio0.03
Book Value/Sh-0.4287 CAD
Cash/Share0.0000 CAD
Dividends
Fwd Div Rate—
Trail. Div Rate0.0000 CAD
Div. Yield—
5Y Avg Yield—
Payout Ratio0.00%
Ex-Div Date—
Pay Date—
Analyst Consensus
Rating—
Target (Mean)—
Target Range—
# Analysts—
Ownership
Shares Out.316.98M
Float221.83M
Insiders26.39%
Institutions0.00%
Short Interest
Short Ratio0.0d
Short % Out.0.00%
Shares Short757
Short (prev mo.)43.34K
Technical
SMA 500.0998 (+10.2%)
SMA 2000.1052 (+4.6%)
Beta—
S&P 52W Chg18.16%
Avg Vol (30d)41.18K
Avg Vol (10d)16.80K
Technical Indicators
RSI (14)57.2
MACD0.0011
MACD Signal0.0005
MACD Hist.+0.0005
BB Upper0.1073 CAD
BB Middle0.1000 CAD
BB Lower0.0927 CAD
BB Width14.51%
ATR (14)0.0058 CAD
Vol Ratio (20d)0.22x